Results 281 to 290 of about 2,693,459 (310)
Some of the next articles are maybe not open access.

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

New England Journal of Medicine, 2022
John J V Mcmurray   +2 more
exaly  

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

New England Journal of Medicine, 2021
Deepak L Bhatt   +2 more
exaly  

Heart Failure

Annals of Internal Medicine, 2023
openaire   +2 more sources

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

New England Journal of Medicine, 2020
Milton Packer   +2 more
exaly  

Novel therapeutic targets for the treatment of heart failure

Nature Reviews Drug Discovery, 2011
Juan Luis Tamargo   +1 more
exaly  

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Lancet, The, 2010
Karl Swedberg   +2 more
exaly  

Heart failure

Home Care Provider, 2000
openaire   +2 more sources

Heart Failure/Congestive Heart Failure

2022
openaire   +1 more source

Advanced Heart Failure

Progress in Cardiovascular Diseases, 2011
Adrian F, Hernandez, G Michael, Felker
openaire   +2 more sources

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine, 2019
Catherine M Viscoli   +2 more
exaly  
humans
3. good health
aged
prognosis
cardiotonic agents
diuretics
adrenergic beta-antagonists
aged, 80 and over
heart-assist devices
previous   27  28  29  30  31  

Home - About - Disclaimer - Privacy